[go: up one dir, main page]

PE20080127A1 - Inhibidores de la adenilato ciclasa soluble - Google Patents

Inhibidores de la adenilato ciclasa soluble

Info

Publication number
PE20080127A1
PE20080127A1 PE2007000334A PE2007000334A PE20080127A1 PE 20080127 A1 PE20080127 A1 PE 20080127A1 PE 2007000334 A PE2007000334 A PE 2007000334A PE 2007000334 A PE2007000334 A PE 2007000334A PE 20080127 A1 PE20080127 A1 PE 20080127A1
Authority
PE
Peru
Prior art keywords
adenylate cyclase
halogen
soluble adenylate
phenylsulfonyl
indol
Prior art date
Application number
PE2007000334A
Other languages
English (en)
Inventor
Bernd Buchmann
Bernd Menzenbach
Kosemund Dirk
Martin Fritsch
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of PE20080127A1 publication Critical patent/PE20080127A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I DONDE R1 ES H, HALOGENO, CF3, ENTRE OTROS; R2 ES HALOGENO, CF3, ENTRE OTROS; R3 ES C6-C12-ARILO, SUSTITUIDO O NO POR HALOGENO, C1-C6-ALQUILO, ENTRE OTROS; R4 ES H, C3-C6-CICLOALQUILO, ENTRE OTROS; R5 ES H, (ALQUILO C1-C6)-(CICLOALQUILO C3-C6), ENTRE OTROS; X ES SULFONILO, (CH2)n o CARBONILO; Y ES -(CH2)n- o -CH=CH-; n ES 1-4. SON COMPUESTOS PREFERIDOS: AMIDA DE ACIDO (E) -3-[5-(4-TER-BUTIL-FENILSULFONIL-AMINO)-3-FENIL-1H-INDOL-2-IL]-N-(TETRAHIDRO-PIRANO-4-IL)-ACRILICO; AMIDA DE ACIDO (E) -3-[5-(4-TER-BUTIL-FENILSULFONIL-AMINO)-3-FENIL-1H-INDOL-2-IL]-N-(2-MORFOLIN-4-IL-ETIL)-ACRILICO; ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. LOS COMPUESTOS DESCRITOS ACTUAN COMO INHIBIDORES DE LA ADENILATO CICLASA SOLUBLE UTILES EN LA ANTICONCEPCION
PE2007000334A 2006-03-23 2007-03-23 Inhibidores de la adenilato ciclasa soluble PE20080127A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006014324A DE102006014324B4 (de) 2006-03-23 2006-03-23 Inhibitoren der löslichen Adenylatzyklase

Publications (1)

Publication Number Publication Date
PE20080127A1 true PE20080127A1 (es) 2008-04-18

Family

ID=38066554

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000334A PE20080127A1 (es) 2006-03-23 2007-03-23 Inhibidores de la adenilato ciclasa soluble

Country Status (13)

Country Link
US (1) US7449459B2 (es)
EP (1) EP2001846A1 (es)
JP (1) JP2009530338A (es)
KR (1) KR20090007352A (es)
CN (1) CN101448788A (es)
AR (1) AR060075A1 (es)
CA (1) CA2647092A1 (es)
DE (1) DE102006014324B4 (es)
DO (1) DOP2007000058A (es)
PE (1) PE20080127A1 (es)
TW (1) TW200815346A (es)
UY (1) UY30235A1 (es)
WO (1) WO2007107383A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101636157A (zh) * 2007-01-12 2010-01-27 康乃尔研究基金会有限公司 作为抗菌干预的新型靶的腺苷酰环化酶
WO2010096830A2 (en) * 2009-02-23 2010-08-26 Cornell University Method to treat psoriasis and other hyperproliferative skin disorders
KR200460239Y1 (ko) * 2012-02-03 2012-05-15 송주근 투광성 패널용 커넥터

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA79504C2 (en) * 2002-11-07 2007-06-25 Organon Nv Indols for treating diseases associated with androgen receptors
HRP20050396A2 (en) 2002-11-07 2005-06-30 Akzo Nobel N.V. Indoles useful in the treatment of androgen-receptor related diseases
DE102004047272A1 (de) * 2004-09-24 2006-04-06 Schering Ag Inhibitoren der löslichen Adenylatzyklase

Also Published As

Publication number Publication date
KR20090007352A (ko) 2009-01-16
DE102006014324A1 (de) 2007-09-27
CN101448788A (zh) 2009-06-03
US7449459B2 (en) 2008-11-11
TW200815346A (en) 2008-04-01
DOP2007000058A (es) 2007-09-30
DE102006014324B4 (de) 2009-01-08
UY30235A1 (es) 2007-10-31
CA2647092A1 (en) 2007-09-27
JP2009530338A (ja) 2009-08-27
US20070232605A1 (en) 2007-10-04
EP2001846A1 (de) 2008-12-17
WO2007107383A1 (de) 2007-09-27
AR060075A1 (es) 2008-05-21

Similar Documents

Publication Publication Date Title
AR051839A1 (es) Metodo para preparar n-fenilpirazol -1- carboxamidas
CR8505A (es) Derivados de (3-oxo-3,4-dihidroquinoxalin-2-il-amino)-benzamida y compuesto relacionado, como inhibidores de glucogeno fosforilasa para el tratamiento de la diabetes y obesidad
PE20080538A1 (es) Derivado heterociclico fusionado y su uso
PE20011371A1 (es) Derivados de 3-(3-isopropil-5-metil-4h-1,2,4-triazol-4-il)-exo-8-azabiciclo[3.2.1]octano como antagonistas de los receptores de quimiocina ccr5
PE20071223A1 (es) Procedimiento de preparacion de derivados de acil-amino-alquilen-amida
AR044743A1 (es) Herbicida, metodo de emplearlo, derivados de tienopirimidina sustituida,compuestos intermediarios, y procedimientos que se utilizan para producirlos,
PE20091376A1 (es) Derivados de fenilamino como moduladores de beta-amiloide
PE20040071A1 (es) Indazoles substituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
TW200745029A (en) Sulfonamide derivatives exhibiting PGD2 receptor antagonism
PE20060777A1 (es) Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
AR059201A1 (es) Compuestos citotoxicos derivados de tomaimicina
CY1112914T1 (el) Υποκατεστημενα παραγωγα ινδολυλ αλκυλ αμινης ως νεοι αναστολεις των αποακετυλασων ιστονης
AR078944A1 (es) Inhibidores de n1-pirazoloespirocetona acetil-coa carboxilasa
WO2007022934A3 (en) Azabicyclo (3, 1, 0) hexan derivatives useful as modulators of dopamine d3 receptors
PE20070833A1 (es) Compuestos de pirimidinil benzotiofeno
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
AR068115A1 (es) Derivado del acido pirazolcarboxilico metodo de produccion del mismo y fungicida
PE20070041A1 (es) Amidas de acido pirazolcarboxilico
PE20140968A1 (es) Derivados de benzamida sustituida
PE20061490A1 (es) Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1
PE20060298A1 (es) Derivados de acido carboxilico de bencimidazolona
PE20080364A1 (es) Acido bifenilcarboxilicos substituidos y sus derivados como moduladores de la actividad de la gamma-secretasa
PE20061295A1 (es) Derivados de acetileno
PE20060727A1 (es) Antranilamidopiridinas como inhibidores de la quinasa receptora del factor de crecimiento vascular endotelial (vegf)
TNSN06338A1 (en) Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an ikb kinase inhibitor

Legal Events

Date Code Title Description
FD Application declared void or lapsed